A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/5575 (2006.01) A61K 9/08 (2006.01) A61K 47/18 (2006.01) A61P 27/06 (2006.01)
Patent
CA 2585691
A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein. A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein.
L'invention concerne une composition comprenant entre 0,005 % et 0,02 % de bimatoprost en poids et entre 100 ppm et 250 ppm de chlorure de benzalkonium, ladite composition étant un liquide aqueux qui est préparé pour l'administration ophtalmique. L'invention concerne également une méthode qui est utile dans le traitement du glaucome ou de l'hypertension oculaire associée à ce dernier.
Chang Chin-Ming
Chang James N.
Chang-Lin Joan-En
Jordan R. Scott
Schiffman Rhett M.
Allergan Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Enhanced bimatoprost ophthalmic solution does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhanced bimatoprost ophthalmic solution, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhanced bimatoprost ophthalmic solution will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1640671